X
XLinkedinWhatsAppTelegramTelegram
0
Read this article in:

FDA finalizes rule for data collection of antimicrobial sales

The final rule also includes an additional reporting provision intended to enhance our understanding of antimicrobial new animal drug sales.

19 May 2016
X
XLinkedinWhatsAppTelegramTelegram
0

The Food and Drug Administration (FDA or we) is issuing a final rule to require that the sponsor of each approved or conditionally approved new animal drug product that contains an antimicrobial active ingredient submit an annual report to us on the amount of each such ingredient in the drug product that is sold or distributed for use in food-producing animals, including information on any distributor-labeled product.

This final rule codifies the reporting requirements established in section 105 of the Animal Drug User Fee Amendments of 2008 (ADUFA).

The final rule also includes an additional reporting provision intended to enhance our understanding of antimicrobial new animal drug sales intended for use in specific food-producing animal species and the relationship between such sales and antimicrobial resistance.

Wednesday, May 11, 2016/ Federal Register/ United States.
https://www.federalregister.gov

Article Comments

This area is not intended to be a place to consult authors about their articles, but rather a place for open discussion among pig333.com users.
Leave a new Comment

Access restricted to 333 users. In order to post a comment you must be logged in.

You are not subscribed to this list pig333.com in 3 minutes

Weekly newsletter with all the pig333.com updates

Log in and sign up on the list

Related articles